{"DataElement":{"publicId":"64771","version":"3","preferredName":"Pathology Tissue Specimen Nuclear Stain DCIS Cell Percentage Value","preferredDefinition":"a percentage expressing the quantity of ductal carcinoma in situ cells identified by dye applied to the nucleus of cells for microscopic assessment of tissue sample by specialist in cellular function.","longName":"P_TSP_NST_DCC_PT_VAL","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2010648","version":"3","preferredName":"Pathology Tissue Specimen Nuclear Stain DCIS Cell","preferredDefinition":"related to ductal carcinoma in situ cells identified by dye applied to the nucleus of the cells for microscopic assessment of a sample of tissue by a specialist in cellular function and changes.","longName":"PA_TI_SP_NU_ST_DC_CE","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2488643","version":"1","preferredName":"Pathology Tissue Specimen","preferredDefinition":"A specialty concerned with the nature and cause of disease as expressed by changes in cellular or tissue structure and function caused by the disease process. (MSH98):is an organ part that consists of similarly specialized cells and intercellular matrix, aggregated according to specific spatial relationships; together with other tissues, it constitutes an organ component. Example(s): epithelium, muscle(tissue), connective tissue, neural tissue, lymphoid tissue.:Specimen; a bit of tissue or blood or urine that is taken or used for research purposes.","longName":"C18189:C12801:C19157","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathology","conceptCode":"C18189","definition":"The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Tissue","conceptCode":"C12801","definition":"An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Specimen","conceptCode":"C19157","definition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"16D5D96F-D639-4A39-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-22","endDate":null,"createdBy":"PWEST","dateCreated":"2006-06-22","modifiedBy":"ONEDATA","dateModified":"2006-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2488981","version":"1","preferredName":"Nuclear Stain DCIS Cell","preferredDefinition":"Pertaining to the nucleus.:A dye or other coloring material that is used in microscopy to make structures visible.:Ductal carcinoma in situ (DCIS) is a carcinoma entirely confined to the mammary ducts.  There is no evidence of invasion of the basement membrane.  Currently, DCIS is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis.  The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS. --2002:The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid. Cells are highly variable and specialized in both structure and function, though all must at some stage replicate proteins and nucleic acids, utilize energy, and reproduce themselves.","longName":"C13361:C841:C2924:C12508","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nuclear","conceptCode":"C13361","definition":"Pertaining to the nucleus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Stain","conceptCode":"C841","definition":"A dye or other coloring material that is used in microscopy to make structures visible.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cell","conceptCode":"C12508","definition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"16EAB645-D2C7-134D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-23","endDate":null,"createdBy":"PWEST","dateCreated":"2006-06-23","modifiedBy":"ONEDATA","dateModified":"2006-06-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"16D75980-DE35-5297-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-22","endDate":null,"createdBy":"PWEST","dateCreated":"2006-06-22","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018830","version":"2","preferredName":"Pathology Specimen Stain Cell Percentage Value","preferredDefinition":"a fraction with the denominator 100 representing a quantity of cells from a sample of tissue or body fluid dyed for microscopic assessment of disease by a specialist in cellular function and changes.","longName":"PA_SPE_ST_CEL_PT_VAL","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"NUMBER","minLength":"1","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":"1","format":"999.9","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208119","version":"1","preferredName":"Percentage Value","preferredDefinition":"Percentage; a fraction or ratio with 100 understood as the denominator.:A numerical quantity measured or assigned or computed.","longName":"C25613:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3E46-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CTEP CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Application","id":"16E70496-9172-05EE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-23","endDate":null,"createdBy":"PWEST","dateCreated":"2006-06-23","modifiedBy":"PWEST","dateModified":"2006-06-23","changeDescription":"revised to change Rep term due to change in Rep term set","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"},{"publicId":"2812245","version":"1","longName":"Phase II Breast Cancer","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811957","version":"1","longName":"Labs","context":"CTEP"},{"publicId":"2811964","version":"1","longName":"Tumor Markers","context":"CTEP"},{"publicId":"2812156","version":"1","longName":"Breast Cancer DataMart","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811932","version":"1","longName":"Pathology Breast","context":"CTEP"},{"publicId":"2811914","version":"1","longName":"Adjuvant Breast","context":"CTEP"},{"publicId":"2811917","version":"1","longName":"Advanced Breast","context":"CTEP"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811891","version":"1","longName":"Phase II","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Percentage of DCIS Cells with","type":"Preferred Question Text","description":"Percentage of DCIS Cells with Nuclear Staining","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Stained DCIS Cell Percentage Nuclear","url":null,"context":"CTEP"}],"origin":"CTEP CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Application","id":"16E4EA65-C765-600C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-23","endDate":null,"createdBy":"PWEST","dateCreated":"2006-06-23","modifiedBy":"REEVESD","dateModified":"2013-05-29","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}